Incyte Corporation (NASDAQ:INCY) saw a downside of -0.69% to close Tuesday at $64.36 after subtracting -$0.45 on the day. The 5-day average trading volume is 1,642,360 shares of the company’s common stock. It has gained $67.03 in the past week. An average of 1,965,705 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,436,414.
INCY’s 1-month performance is -11.17% or -$6.76 on its low of $64.20 reached on 10/12/21. The company’s shares have touched a 52-week low of $64.77 and high of $101.47, with the stock’s rally to the 52-week high happening on 01/25/21. YTD, INCY has lost -26.01% or -$22.62. However, the current price is down -36.57%% from the 52-week high price.
A Backdoor Way To Profit From Today’s Crypto Bull Market
In any crypto bull market, there's a lot of money to be made.
But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?
This strategy is simply and ridiculously easy.
Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.
On Oct 01, 12 days have gone by since the last insider trading activity for Incyte Corporation (INCY). Dhanak Dashyant (EVP & Chief Scientific Officer) most recently sold 389 shares at $68.67 per share on Oct 01. This transaction cost the insider $26,713. EVP & Chief Scientific Officer, Dhanak Dashyant, sold 388 shares at a price of $76.71 on Sep 01. Then, on Aug 02, EVP & Chief Scientific Officer Dhanak Dashyant sold 389 shares at a price of $77.49 per share. This transaction amounted to $30,144.
The company’s PE ratio for the last five years has touched a high of 282.70 and a low of 30.82. INCY stock has a beta of 0.78. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 5.21 while the price-to-book (PB) in the most recent quarter is 4.82, with the price to cash flow ratio at 31.48.
Incyte Corporation’s quick ratio for the period ended June 29 was 3.90, with the current ratio over the same period at 4.00 meaning that INCY stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.01, while the total debt to equity was 0.01. In terms of profitability, the gross margin trailing 12 months is 95.70%. The trailing 12-month EBITDA margin is -7.07% while for the period ending June 29; Incyte Corporation’s operating margin was 15.00%. The firm’s gross profit as reported stood at $2.54 billion against revenue of $2.67 billion.
For the quarterly period ending June 29 this year, Incyte Corporation’s cash and short-term investments amounted to $283.39 million against total debt of $60.74 million. Net income and sales went up compared to those figures reported in the previous quarter. Analysts expected INCY to announce $0.74 per share in earnings in its latest quarter, but it posted $0.8, representing a 8.10% surprise. EBITDA for the quarter stood at more than $155.29 million. INCY stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 968.76 million, with total debt at $60.74 million. Shareholders hold equity totaling $220.84 million
Let’s look briefly at Incyte Corporation (INCY) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 20.28% to suggest the stock is trending oversold, with historical volatility in this time period at 15.82%.
The stock’s 5-day moving average is $65.31, reflecting a -1.48% or -$0.97 change from its current price. INCY is currently trading -10.91% above its 20-day SMA, -22.93% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -17.98% and -26.34% respectively.
Stochastic %K and %D was 4.13% and 5.61% and the average true range (ATR) pointed at 1.51. The RSI (14) points at 24.76%, while the 14-day stochastic is at 2.66% with the period’s ATR at 1.62. The stock’s 9-day MACD Oscillator is pointing at -1.11 and -2.16 on the 14-day charts.
In the most recent analyst report for Incyte Corporation (NASDAQ: INCY), The Benchmark Company upgraded it to a Buy rating. They previously had a Hold rating on the stock. Analysts offering their rating for INCY stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate INCY as a “sell,”, while 8 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 12 have offered a “buy” rating.
What is INCY’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $66.00 and a high of $134.00, with their median price target at $98.00. Looking at these predictions, the average price target given by analysts is for Incyte Corporation (INCY) stock is $99.53.